Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Energy Vault (NYSE:NRGV) Q3 Revenue Falls 61% to USD 13.1 Million as Backlog Reaches USD 2.3 Billion

Contract backlog reached USD 2.3 billion, up about 15% from the prior quarter and 147% from a year earlier. Management said about 35% to 40% of it converts over the next 12 to 15 months, with a build and transfer backlog of about USD …

Nitish Kishor | 12 November 2026

NextCure (NASDAQ:NXTC) Q3 Net Loss Narrows to USD 6.8 Million as Court Validates Reverse Split and Going Concern Note Remains

Research and development expense decreased USD 1.6 million in the quarter and USD 19.3 million for the nine months, while general and administrative expense increased USD 1.6 million in the quarter and USD 0.6 million for the nine months.

Nitish Kishor | 12 November 2026

Orchestra BioMed Holdings (NASDAQ:OBIO) Reports Q3 Net Loss of USD 18.8 Million and USD 101.9 Million in Cash and Securities

Net loss attributable to common stockholders was USD 19.62 million after a USD 867,000 adjustment to the carrying value of Series A Preferred Stock. Product revenue fell USD 49,000, or about 35%, to USD 91,000, and cost of product revenues was USD 28,000 against …

Nitish Kishor | 12 November 2026

ODDITY Tech (NYSE:ODD) Beats Q3 Estimates With EPS of USD 0.37 and Raises 2026 Outlook

Management said net revenue declined 2% from the prior year to USD 145 million, better than its outlook of approximately a 5% decline and a substantial sequential improvement from the 25% decline reported in the second quarter. More than 80% of third quarter net …

Nitish Kishor | 12 November 2026

Orion180 Insurance Group (NASDAQ:OIG) Posts Q3 Revenue of USD 53.9 Million in First Earnings Report as a Public Company

Management said revenue growth reflected a 52% increase in net premiums earned and a 70% increase in policy fee income. Commission and fee revenue grew 64% to USD 75.1 million.

Nitish Kishor | 12 November 2026

What Investors Are Watching at Olema Pharmaceuticals (NASDAQ:OLMA) After Q3 Results

General and administrative expenses for the nine months rose USD 13.9 million, or 99%, from the same period of 2025, which sits alongside a net loss that was up about 63% from USD 116.4 million. Costs incurred under its 2024 agreement with Novartis are …

Nitish Kishor | 12 November 2026

Why Did On Holding (NYSE:ONON) Post a Record Third Quarter With CHF 931 Million in Sales?

Every region, channel and category contributed. Direct-to-consumer sales rose 25.0% as reported to CHF 393.3 million, lifting that channel to 42.2% of sales, up 2.6 percentage points. Wholesale grew 12.2% as reported to CHF 538.2 million. Footwear rose 16%, apparel 38% and accessories 40.2%, …

Nitish Kishor | 12 November 2026

OptimizeRx (NASDAQ:OPRX) Tops Q3 Estimates With Non-GAAP EPS of USD 0.20 as Revenue Falls 17%

Management said revenue of USD 21.6 million was a decrease of 17% from USD 26.1 million in the third quarter of 2025, and that revenue and adjusted EBITDA of USD 6.3 million both exceeded consensus expectations.

Nitish Kishor | 12 November 2026

Ovid Therapeutics (NASDAQ:OVID) Q3 Loss of USD 0.10 Per Share as Epilepsy Programs Advance

At September 30 the company held USD 161.4 million in cash, cash equivalents and marketable securities, with working capital of USD 130.1 million and an accumulatedDeficitof USD 374.5 million. Management stated the balance is sufficient to fund current operating plans for at least the …

Nitish Kishor | 12 November 2026

Palisade Bio (NASDAQ:PALI) Reports Q3 Net Loss of USD 14.6 Million and Nine-Month Share-Based Compensation of USD 14.1 Million

For the nine months, net loss was USD 34.80 million, or USD 0.16 per share, against USD 7.88 million, or USD 1.38 per share. Total other income, net was USD 1.08 million against USD 54,000 for the quarter.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…